StockNews.com began coverage on shares of Phibro Animal Health (NASDAQ:PAHC – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the stock.
Separately, Morgan Stanley decreased their price target on shares of Phibro Animal Health from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Thursday, February 9th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and an average target price of $18.00.
Phibro Animal Health Price Performance
Shares of PAHC stock opened at $14.05 on Thursday. Phibro Animal Health has a 12-month low of $11.75 and a 12-month high of $20.54. The firm has a market capitalization of $569.03 million, a price-to-earnings ratio of 19.79, a price-to-earnings-growth ratio of 7.55 and a beta of 0.61. The company has a quick ratio of 1.77, a current ratio of 3.54 and a debt-to-equity ratio of 1.71. The firm has a fifty day moving average of $15.02 and a 200-day moving average of $14.56.
Hedge Funds Weigh In On Phibro Animal Health
About Phibro Animal Health
Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines.
- Get a free copy of the StockNews.com research report on Phibro Animal Health (PAHC)
- 5 Best Bank ETFs to Buy Now
- How to Invest in Telehealth and Telemedicine Stocks
- Target’s Guidance Looms Over The Market
- Want Clean Energy? Siemens May Be Pointing To A Breakout
- Up Over 2,600% in 5 Years, Wall Street Still Calls Celsius a Buy
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.